about
Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitorsElucidation of hepatitis C virus transmission and early diversification by single genome sequencingH3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccinationA North American multilaboratory study of CD4 counts using flow cytometric panLeukogating (PLG): a NIAID-DAIDS Immunology Quality Assessment Program Study.CD4 immunophenotyping in HIV infection.A model for harmonizing flow cytometry in clinical trials.Tissue-specific genetic control of splicing: implications for the study of complex traitsEvaluation and recommendations on good clinical laboratory practice guidelines for phase I-III clinical trials.Overexpression of p21(waf1) in human T-cell lymphotropic virus type 1-infected cells and its association with cyclin A/cdk2.Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccinationAssessing immunophenotyping performance: proficiency-validation for adopting improved flow cytometry methods.Development of a contemporary globally diverse HIV viral panel by the EQAPOL programStatistical methods for the assessment of EQAPOL proficiency testing: ELISpot, Luminex, and Flow Cytometry.Comparison of human immunodeficiency virus antigens as stimulants for lymphocyte proliferation assaysVERITAS?: A time for VERIQAS™ and a new approach to training, education, and the quality assessment of CD4+ T lymphocyte counting (I).Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the External Quality Assurance Program Oversight Laboratory (EQAPOL).Phenotypic properties of transmitted founder HIV-1Origin and evolution of HIV-1 in breast milk determined by single-genome amplification and sequencing.Comparison of interlaboratory variation in absolute T-cell counts by single-platform and optimized dual-platform methodsHIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodiesInitial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutatedInitial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replicationQuality assurance program for peripheral blood mononuclear cell cryopreservation.Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccineesInfluence of HLA-C expression level on HIV controlCorrelates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure.Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV.Flow cytometric methods for prenatal and neonatal diagnosis.Paradoxical effects of a stress signal on pro- and anti-apoptotic machinery in HTLV-1 Tax expressing cells.IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba.Immunologic targets of HIV infection: T cells. NICHD IVIG Clinical Trial Group, and the NHLBI P2C2 Pediatric Pulmonary and Cardiac Complications of HIV Infection Study Group.Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design.Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients.Basic fibroblast growth factor downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells.High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies.The dynamics of bone marrow stromal cells in the proliferation of multipotent hematopoietic progenitors by substance P: an understanding of the effects of a neurotransmitter on the differentiating hematopoietic stem cell.Effect of human immunodeficiency virus infection on serum beta2-microglobulin levels in pregnant women.CD3+CD8+ cell levels as predictors of transmission in human immunodeficiency virus-infected couples: a report from the heterosexual HIV transmission study.Lymphocyte immunoregulatory cells present in semen from human immunodeficiency virus (HIV)-infected individuals: a report from the HIV Heterosexual Transmission Study.P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials.
P50
Q28344365-6C801D95-12E9-4484-9B43-48B03E9A2DE0Q28482493-5087E71F-D14D-46B3-9A21-FFFFEDF7FA13Q28743596-EFC6E94B-8CDC-4FB9-9162-AD2C4E3E8ED2Q30368321-1E095FE5-2A4E-49EA-BF44-72DD983118FFQ30372724-9DF6161D-8924-4EEB-8F6B-EB72838AB728Q30425924-16805E21-1E26-4EC8-984A-3999C109823BQ33409947-D19BB2A6-86B1-42DB-9BB8-C3B0170D4E9BQ33470284-78A00768-8834-4788-A437-5D5D984DD894Q33809384-A92B5C4B-9C17-4A31-B14A-DEF21AE92871Q33826974-F2694D54-196E-4EDE-96D5-79751B89AED9Q33908051-524894E8-B3D1-40E5-8896-C8A411F66BD1Q33922689-EDF59F02-B9A3-4E1F-AB87-101D86D74675Q33923216-CFAB6389-AE41-4FE3-A373-E11446C2A6C6Q33943064-CEC7FE2C-6010-4D8A-905A-BD1C12C5D06AQ34018989-0A005338-8123-49C6-B2A7-49199F4EBE3FQ34062312-44F1E602-F7DC-4FB1-AE6F-E5B985B925CDQ34336058-EABFA34A-620D-4523-ACE3-DDFD541A6384Q34742873-E1782489-A004-47EB-B918-6E3697BCBFBCQ34912964-5ECE227C-0059-481D-9502-28BAE279BBD8Q35192641-A5CE40D0-3A41-4A87-B508-94B69D3D76B5Q35441583-1B3E497A-7778-45C3-812A-C7F3EF70BC4FQ36086631-97071CE0-05D5-42B4-AF0C-5BE491C39718Q36095112-1AEBB884-D5DE-4713-9BFD-50B655A2FD0EQ36978671-4849AB4C-F283-4FFC-948C-D7008AEC6694Q37200459-C3D74073-DA38-429B-85A6-DF6BCE92E045Q37344616-E8B44795-E8E8-450E-B29B-43D2235F4A40Q37625296-0C27E113-EB74-40BF-90B8-ABF42C931C55Q37798905-46F6A5E6-AC71-4539-94E7-F46D8D465E29Q38965830-E09DBC0F-514E-410B-88A1-B6773028FD97Q39372304-E327F6E6-B045-4243-BA7D-969A6D2253ADQ40619254-29A48359-2D2B-4C2A-8E75-F3A48CE8CAE8Q41338220-A4840244-3213-4BEB-AE9E-4EC6CF7A3B95Q42442648-3D0E30A1-2A7B-4AEA-AE01-42FB879EBDDAQ42832716-58962CE7-18AD-4CCE-A91F-295262A3334CQ42939116-8B1F56B1-F321-48C3-BE03-9F7D9365BA93Q43813957-3F1124CB-55CB-445E-AB46-B9C7633666D2Q44514912-2FBF757B-0B9B-4763-91EA-442B79464048Q45753577-A0030C11-01E8-4641-9C15-69D3F0B4AD00Q45768197-0D31294D-F320-4F52-A5B3-8893B23428C2Q47163740-6EE6158F-F45D-458B-88CD-72D052C9D27B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Thomas Denny
@ast
Thomas Denny
@en
Thomas Denny
@es
Thomas Denny
@nl
Thomas Denny
@sl
type
label
Thomas Denny
@ast
Thomas Denny
@en
Thomas Denny
@es
Thomas Denny
@nl
Thomas Denny
@sl
prefLabel
Thomas Denny
@ast
Thomas Denny
@en
Thomas Denny
@es
Thomas Denny
@nl
Thomas Denny
@sl
P106
P108
P1153
7005696879
P21
P31
P496
0000-0002-7364-8276